SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-020767
Filing Date
2018-08-09
Accepted
2018-08-09 08:18:40
Documents
75
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 MELINTA Q2 10-Q mlnt-10q_20180630.htm 10-Q 1768140
2 EX-10.2 mlnt-ex102_330.htm EX-10.2 13989
3 EX-31.1 mlnt-ex311_6.htm EX-31.1 17159
4 EX-31.2 mlnt-ex312_8.htm EX-31.2 17118
5 EX-32.1 mlnt-ex321_9.htm EX-32.1 6410
6 EX-32.2 mlnt-ex322_7.htm EX-32.2 6341
  Complete submission text file 0001564590-18-020767.txt   9959033

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mlnt-20180630.xml EX-101.INS 2502091
8 XBRL TAXONOMY EXTENSION SCHEMA mlnt-20180630.xsd EX-101.SCH 73549
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mlnt-20180630_cal.xml EX-101.CAL 56159
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mlnt-20180630_def.xml EX-101.DEF 332929
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mlnt-20180630_lab.xml EX-101.LAB 585565
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mlnt-20180630_pre.xml EX-101.PRE 477197
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35405 | Film No.: 181003522
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences